Commission Implementing Regulation (EU) 2026/700 of 4 March 2026 amending Implementing Regulation (EU) 2024/2651 as regards administrative changes to the Union authorisation of the biocidal product family Taski-Room Care-Suma Family based on Lactic Acid

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular Article 50(2) thereof,

Whereas:

(1) On 10 October 2024, Commission Implementing Regulation (EU) 2024/2651 (2) granted a Union authorisation, under number EU-0031644-0000, to Diversey Europe Operations B.V. for the making available on the market and use of the biocidal product family ‘Taski-Room Care-Suma Family Based on Lactic Acid’. The Annex to that Implementing Regulation provides the summary of product characteristics for that biocidal product family.

(2) On 9 April 2025, Diversey Europe Operations B.V. submitted to the European Chemicals Agency (‘the Agency’), in accordance with Article 11(1) of Commission Implementing Regulation (EU) No 354/2013 (3), a notification of administrative changes to the Union authorisation for the biocidal product family ‘Taski-Room Care-Suma Family Based on Lactic Acid’, recorded in the Register for Biocidal Products (‘Register’) under case number BC-KW105377-13. The notified proposed changes to that authorisation concern changes to the address of the authorisation holder and the biocidal product manufacturer.

(3) On 28 April 2025, the Agency submitted to the Commission, in accordance with Article 11(3) of Implementing Regulation (EU) No 354/2013, an opinion (4) on the notified administrative changes to the Union authorisation for the biocidal product family ‘Taski-Room Care-Suma Family Based on Lactic Acid’. In its opinion, the Agency concluded that the proposed changes are administrative changes as referred to in Article 50(3), point (a), of Regulation (EU) No 528/2012 and as specified in Title 1 of the Annex to Implementing Regulation (EU) No 354/2013, and that, after the implementation of the changes, the conditions of Article 19 of Regulation (EU) No 528/2012 will still be met.

(4) On 28 April 2025, the Agency transmitted to the Commission a revised summary of product characteristics for the biocidal product family ‘Taski-Room Care-Suma Family Based on Lactic Acid’ in all official languages of the Union, covering the administrative changes applied for, in accordance with Article 11(6) of Implementing Regulation (EU) No 354/2013.

(5) The Commission concurs with the opinion of the Agency and therefore considers it appropriate to amend the Union authorisation for the biocidal product family ‘Taski-Room Care-Suma Family Based on Lactic Acid’ to introduce the administrative changes requested by Diversey Europe Operations B.V..

(6) Except for the amendments regarding the proposed administrative changes, all other information included in the summary of product characteristics of ‘Taski-Room Care-Suma Family Based on Lactic Acid’, as set out in the Annex to Implementing Regulation (EU) 2024/2651, remains unchanged.

(7) In order to enhance clarity and to ease the access of users and interested parties to the consolidated version of the summary of product characteristics which is to be published by the Agency, the Annex to Implementing Regulation (EU) 2024/2651 should be replaced in its entirety. Due to a change in the format used for the generation of the summary of product characteristics in the Register in February 2024, the summary of product characteristics in that Annex should also include some minor editorial and layout changes.

(8) Implementing Regulation (EU) 2024/2651 should therefore be amended accordingly,

HAS ADOPTED THIS REGULATION:

Article 1

The Annex to Implementing Regulation (EU) 2024/2651 is replaced by the text set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 4 March 2026.

For the Commission The President Ursula VON DER LEYEN

(1) OJ L 167, 27.6.2012, p. 1, ELI: http://data.europa.eu/eli/reg/2012/528/oj.

(2) Commission Implementing Regulation (EU) 2024/2651 of 10 October 2024 granting a Union authorisation for the biocidal product family Taski-Room Care-Suma Family based on Lactic Acid in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2024/2651, 11.10.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/2651/oj).

(3) Commission Implementing Regulation (EU) No 354/2013 of 18 April 2013 on changes of biocidal products authorised in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 109, 19.4.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/354/oj).

(4) ECHA Opinion No UAD-C-1818195-15-00/F of 28 April 2025 on the administrative changes of the Union authorisation of the biocidal product family ‘Taski-Room Care-Suma Family Based on Lactic Acid’, https://echa.europa.eu/opinions-on-applications-for-union-authorisation.